DNA methylation at CpGs (−373 and −456) within the promotor of the IL2RA gene was slightly higher in T1D patients than in controls (142), indicating that epigenetic changes in the IL2RA promotor might participate in the IL2RA risk allele for T1D. This evidence concerns the gene IL2RA and type 1 diabetes mellitus.